Peptide-Mediated Delivery of Nucleic Acids into Mammalian Cells
- 1 January 2007
- book chapter
- Published by Springer Nature
- Vol. 386, 299-308
Abstract
Control of gene expression using RNA interference (RNAi) technology constitutes a method of choice for investigating gene function in mammalian cells. However, like most oligonucleotide-based strategies, the major limitation of interfering RNA is their poor cellular uptake due to low permeability of the cell membrane to nucleic acids. Several strategies have been developed to improve delivery of oligonucleotides both in cultured cells and in vivo. So far, there is no universal method for their delivery, as they all present several limitations. Peptide-based strategies have been demonstrated to improve the cellular uptake of nucleic acids both in cultured cell and in vivo. This chapter describes a new peptide-based gene delivery system, MPG, which forms stable noncovalent complexes with oligonucleotides and promotes their delivery into a large panel of cell lines without the need for prior chemical covalent coupling. Protocols are described for both adherent and suspension cell lines.Keywords
This publication has 22 references indexed in Scilit:
- siRNA delivery technologies for mammalian systemsTARGETS, 2003
- Local gene knockdown in the brain using viral-mediated RNA interferenceNature Medicine, 2003
- Insight into the mechanism of the peptide-based gene delivery system MPG: implications for delivery of siRNA into mammalian cellsNucleic Acids Research, 2003
- RNA interference targeting Fas protects mice from fulminant hepatitisNature Medicine, 2003
- siRNA-mediated gene silencing in vitro and in vivoNature Biotechnology, 2002
- Stable suppression of tumorigenicity by virus-mediated RNA interferenceCancer Cell, 2002
- Efficient delivery of siRNA for inhibition of gene expression in postnatal miceNature Genetics, 2002
- RNA interference in adult miceNature, 2002
- Vectorial delivery of macromolecules into cells using peptide-based vehiclesTrends in Biotechnology, 2001
- Synthetic DNA delivery systemsNature Biotechnology, 2000